Cancer Center Support Grant View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1976-2022

FUNDING AMOUNT

31260434 USD

ABSTRACT

Project Summary Over the past 5 years, the Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) has continued its upward trajectory in cancer research excellence and service to its catchment area. The WFBCCC catchment area includes the Piedmont and southern Appalachia, a region of 58 contiguous counties in North Carolina, Virginia, West Virginia and Tennessee. The majority of this region is rural and exhibits significant racial health disparities. Elevated age-adjusted smoking rates, obesity rates, cancer incidence, and cancer mortality are observed across the WFBCCC catchment area when compared with the rest of the U.S. To target these issues, the WFBCCC conducts cutting-edge basic, clinical, and population research on the prevention, detection and treatment of cancer, and translates this knowledge into strategies to improve patient outcomes and reduce the incidence of cancer. WFBCCC cancer research funding is $37.9 million, of which over $14.9 million comes from the NCI; this represents a 25.3% increase in total cancer funding since the last CCSG renewal. Center research space under the Director?s authority increased by approximately 65,000 square feet, and the WFBCCC clinical facilities have been dramatically enhanced with the completion of the new eleven- story Cancer Hospital in 2013. This building houses all oncology inpatients and outpatients. The Center?s 127 members span the basic, clinical and population sciences and are organized into 4 Programs with substantial inter-and intra-programmatic productivity. Faculty additions enhanced tobacco control, tobacco-related cancer research, and precision medicine. Substantial investment in faculty, technology, and informatics significantly expanded cancer genomics capabilities. Enrollment of patients into treatment trials reached an all-time high in 2015, with a large increase in the number of patients enrolled in investigator-initiated trials. WFBCCC population scientists initiated exciting new efforts in cancer prevention and survivorship. Clinical scientists completed practice-changing studies in patients with glioma and lung cancer. Groundbreaking observations in prostate cancer emerged from WFBCCC inter-programmatic collaborations. WFBCCC basic science Programs continued to make high impact observations that are being translated into human therapeutics. The WFBCCC requests continued CCSG funding for 4 scientific Programs; 7 Shared Resources; 2 clinical research components; administration and leadership; planning and evaluation; and developmental funds. With these funds, a talented faculty integrated throughout the Cancer Center will make advances in the prevention, early detection, and treatment of cancer in the WFBCCC catchment area and the nation. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9422670

Related SciGraph Publications

  • 2019-12. IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling in NATURE COMMUNICATIONS
  • 2019-02-14. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC in ONCOGENE
  • 2019-02-06. ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness in BREAST CANCER RESEARCH AND TREATMENT
  • 2019-02. SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis in NATURE CELL BIOLOGY
  • 2019-02. Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2019-01-22. Elevated leptin disrupts epithelial polarity and promotes premalignant alterations in the mammary gland in ONCOGENE
  • 2019. Models of Prostate Cancer Bone Metastasis. in BONE RESEARCH PROTOCOLS
  • 2018-12-15. Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia in SUPPORTIVE CARE IN CANCER
  • 2018-12. Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells in SCIENTIFIC REPORTS
  • 2018-12. The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance in NATURE COMMUNICATIONS
  • 2018-12. Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1 in MOLECULAR CANCER
  • 2018-12. In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening in SCIENTIFIC REPORTS
  • 2018-12. Mitochondria-targeted Probes for Imaging Protein Sulfenylation in SCIENTIFIC REPORTS
  • 2018-11. Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-11. Chemical proteomics reveals new targets of cysteine sulfinic acid reductase in NATURE CHEMICAL BIOLOGY
  • 2018-10. Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy in CURRENT OSTEOPOROSIS REPORTS
  • 2018-10. miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways in ONCOGENE
  • 2018-09. Thrombospondin-1 interactions regulate eicosanoid metabolism and signaling in cancer-related inflammation in CANCER AND METASTASIS REVIEWS
  • 2018-06-02. Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes in REPORTER GENE IMAGING
  • 2018-06-02. Synthesis, Purification, Characterization, and Imaging of Cy3-Functionalized Fluorescent Silver Nanoparticles in 2D and 3D Tumor Models in REPORTER GENE IMAGING
  • 2018-05. Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer in ONCOGENE
  • 2018-04. The impact of obesity on outcomes for patients undergoing mastectomy using the ACS-NSQIP data set in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-03. PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries in ANNALS OF SURGICAL ONCOLOGY
  • 2018-02. Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis in CALCIFIED TISSUE INTERNATIONAL
  • 2018-02. Preclinical and clinical studies on cancer-associated cachexia in FRONTIERS IN BIOLOGY
  • 2018-01. Substrate specificity and membrane topologies of the iron-containing ω3 and ω6 desaturases from Mortierella alpina in APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
  • 2017-12. “UPRegulation” of CD47 by the endoplasmic reticulum stress pathway controls anti-tumor immune responses in BIOMARKER RESEARCH
  • 2017-12. The Effects of Travel Burden on Outcomes After Resection of Extrahepatic Biliary Malignancies: Results from the US Extrahepatic Biliary Consortium in JOURNAL OF GASTROINTESTINAL SURGERY
  • 2017-12. Adeno-associated virus serotype rh10 is a useful gene transfer vector for sensory nerves that innervate bone in immunodeficient mice in SCIENTIFIC REPORTS
  • 2017-12. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2017-12. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform in SCIENTIFIC REPORTS
  • 2017-11. Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram in JOURNAL OF NEURO-ONCOLOGY
  • 2017-08. Process Evaluation of a Community Garden at an Urban Outpatient Clinic in JOURNAL OF COMMUNITY HEALTH
  • 2017-04. Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC) in ANNALS OF SURGICAL ONCOLOGY
  • 2016-12. Conservation of immune gene signatures in solid tumors and prognostic implications in BMC CANCER
  • 2016-12. Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in ANNALS OF SURGICAL ONCOLOGY
  • 2016-10. Longitudinal Reciprocal Relationships Between Quality of Life and Coping Strategies Among Women with Breast Cancer in ANNALS OF BEHAVIORAL MEDICINE
  • 2016-09. Quantifying mammalian genomic DNA hydroxymethylcytosine content using solid-state nanopores in SCIENTIFIC REPORTS
  • 2016-08. Vulnerable characteristics and interest in wellness programs among head and neck cancer caregivers in SUPPORTIVE CARE IN CANCER
  • 2016-05. Routine Admission to Intensive Care Unit After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: Not Always a Requirement in ANNALS OF SURGICAL ONCOLOGY
  • 2016-04. Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative in ANNALS OF SURGICAL ONCOLOGY
  • 2016-02. Stoma Creation and Reversal After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in ANNALS OF SURGICAL ONCOLOGY
  • 2016-02. Conditional Survival After Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Low- and High-Grade Appendiceal Primaries in ANNALS OF SURGICAL ONCOLOGY
  • 2016-02. The border-to-border distribution method for analysis of cytoplasmic particles and organelles in CELL AND TISSUE RESEARCH
  • 2015-12. Tumor-induced loss of mural Connexin 43 gap junction activity promotes endothelial proliferation in BMC CANCER
  • 2015-11. Disparities in barriers to follow-up care between African American and White breast cancer survivors in SUPPORTIVE CARE IN CANCER
  • 2015-10. Trajectories of Posttraumatic Growth and Associated Characteristics in Women with Breast Cancer in ANNALS OF BEHAVIORAL MEDICINE
  • 2015-10. Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro in ANNALS OF BIOMEDICAL ENGINEERING
  • 2015-09. Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design in JOURNAL OF NEURO-ONCOLOGY
  • 2015-09. miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α in ONCOGENE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "31260434"
        }, 
        "description": "Project Summary Over the past 5 years, the Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) has continued its upward trajectory in cancer research excellence and service to its catchment area. The WFBCCC catchment area includes the Piedmont and southern Appalachia, a region of 58 contiguous counties in North Carolina, Virginia, West Virginia and Tennessee. The majority of this region is rural and exhibits significant racial health disparities. Elevated age-adjusted smoking rates, obesity rates, cancer incidence, and cancer mortality are observed across the WFBCCC catchment area when compared with the rest of the U.S. To target these issues, the WFBCCC conducts cutting-edge basic, clinical, and population research on the prevention, detection and treatment of cancer, and translates this knowledge into strategies to improve patient outcomes and reduce the incidence of cancer. WFBCCC cancer research funding is $37.9 million, of which over $14.9 million comes from the NCI; this represents a 25.3% increase in total cancer funding since the last CCSG renewal. Center research space under the Director?s authority increased by approximately 65,000 square feet, and the WFBCCC clinical facilities have been dramatically enhanced with the completion of the new eleven- story Cancer Hospital in 2013. This building houses all oncology inpatients and outpatients. The Center?s 127 members span the basic, clinical and population sciences and are organized into 4 Programs with substantial inter-and intra-programmatic productivity. Faculty additions enhanced tobacco control, tobacco-related cancer research, and precision medicine. Substantial investment in faculty, technology, and informatics significantly expanded cancer genomics capabilities. Enrollment of patients into treatment trials reached an all-time high in 2015, with a large increase in the number of patients enrolled in investigator-initiated trials. WFBCCC population scientists initiated exciting new efforts in cancer prevention and survivorship. Clinical scientists completed practice-changing studies in patients with glioma and lung cancer. Groundbreaking observations in prostate cancer emerged from WFBCCC inter-programmatic collaborations. WFBCCC basic science Programs continued to make high impact observations that are being translated into human therapeutics. The WFBCCC requests continued CCSG funding for 4 scientific Programs; 7 Shared Resources; 2 clinical research components; administration and leadership; planning and evaluation; and developmental funds. With these funds, a talented faculty integrated throughout the Cancer Center will make advances in the prevention, early detection, and treatment of cancer in the WFBCCC catchment area and the nation.", 
        "endDate": "2022-01-31T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.48336.3a", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2438796", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2438796"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "P30CA012197"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "new eleven- story Cancer Hospital", 
          "technology", 
          "early detection", 
          "time", 
          "treatment", 
          "Shared Resources", 
          "population science", 
          "population research", 
          "cancer", 
          "outpatients", 
          "detection", 
          "programmatic collaborations", 
          "Cancer Center Support Grant", 
          "buildings", 
          "patients", 
          "last CCSG renewal", 
          "WFBCCC population scientists", 
          "WFBCCC catchment area", 
          "human therapeutics", 
          "upward trajectory", 
          "treatment trials", 
          "incidence", 
          "Scientific Programs", 
          "planning", 
          "cancer incidence", 
          "exciting new efforts", 
          "square feet", 
          "cancer prevention", 
          "WFBCCC clinical facilities", 
          "prevention", 
          "strategies", 
          "years", 
          "oncology inpatients", 
          "funds", 
          "number", 
          "knowledge", 
          "developmental funds", 
          "substantial investment", 
          "rest", 
          "enhanced tobacco control", 
          "smoking rates", 
          "clinical research components", 
          "patient outcomes", 
          "Virginia", 
          "West Virginia", 
          "completion", 
          "services", 
          "precision medicine", 
          "NCI", 
          "cancer center", 
          "high impact observations", 
          "WFBCCC", 
          "faculty additions", 
          "significant racial health disparities", 
          "survivorship", 
          "increase", 
          "talented faculty", 
          "practice", 
          "informatics", 
          "project summaries", 
          "issues", 
          "southern Appalachia", 
          "prostate cancer", 
          "region", 
          "Tennessee", 
          "leadership", 
          "substantial inter", 
          "elevated age", 
          "Center research space", 
          "contiguous counties", 
          "majority", 
          "WFBCCC cancer research funding", 
          "observations", 
          "obesity rates", 
          "faculty", 
          "glioma", 
          "North Carolina", 
          "cancer research", 
          "lung cancer", 
          "nation", 
          "administration", 
          "trials", 
          "Piedmont", 
          "Center?s 127 members", 
          "intra-programmatic productivity", 
          "WFBCCC requests", 
          "cancer genomics capabilities", 
          "tobacco", 
          "enrollment", 
          "cancer mortality", 
          "U.S.", 
          "program", 
          "total cancer funding", 
          "clinical scientists", 
          "Director?s authority", 
          "evaluation", 
          "advances", 
          "investigators", 
          "catchment area", 
          "cancer research excellence", 
          "large increase", 
          "study", 
          "CCSG funding", 
          "WFBCCC basic science Programs"
        ], 
        "name": "Cancer Center Support Grant", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.412860.9", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.412860.9", 
              "name": "WAKE FOREST UNIVERSITY HEALTH SCIENCES", 
              "type": "Organization"
            }, 
            "familyName": "PASCHE", 
            "givenName": "BORIS", 
            "id": "sg:person.0667063306.79", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.0667063306.79", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2438796"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2019-03-07T12:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_4.xml.gz", 
        "startDate": "1976-03-01T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9422670"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2438796'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2438796'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2438796'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2438796'


     

    This table displays all metadata directly associated to this object as RDF triples.

    148 TRIPLES      19 PREDICATES      125 URIs      117 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2438796 schema:about anzsrc-for:2211
    2 schema:amount N2214ca9064e54634b3aadd1e45cc2ae5
    3 schema:description Project Summary Over the past 5 years, the Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) has continued its upward trajectory in cancer research excellence and service to its catchment area. The WFBCCC catchment area includes the Piedmont and southern Appalachia, a region of 58 contiguous counties in North Carolina, Virginia, West Virginia and Tennessee. The majority of this region is rural and exhibits significant racial health disparities. Elevated age-adjusted smoking rates, obesity rates, cancer incidence, and cancer mortality are observed across the WFBCCC catchment area when compared with the rest of the U.S. To target these issues, the WFBCCC conducts cutting-edge basic, clinical, and population research on the prevention, detection and treatment of cancer, and translates this knowledge into strategies to improve patient outcomes and reduce the incidence of cancer. WFBCCC cancer research funding is $37.9 million, of which over $14.9 million comes from the NCI; this represents a 25.3% increase in total cancer funding since the last CCSG renewal. Center research space under the Director?s authority increased by approximately 65,000 square feet, and the WFBCCC clinical facilities have been dramatically enhanced with the completion of the new eleven- story Cancer Hospital in 2013. This building houses all oncology inpatients and outpatients. The Center?s 127 members span the basic, clinical and population sciences and are organized into 4 Programs with substantial inter-and intra-programmatic productivity. Faculty additions enhanced tobacco control, tobacco-related cancer research, and precision medicine. Substantial investment in faculty, technology, and informatics significantly expanded cancer genomics capabilities. Enrollment of patients into treatment trials reached an all-time high in 2015, with a large increase in the number of patients enrolled in investigator-initiated trials. WFBCCC population scientists initiated exciting new efforts in cancer prevention and survivorship. Clinical scientists completed practice-changing studies in patients with glioma and lung cancer. Groundbreaking observations in prostate cancer emerged from WFBCCC inter-programmatic collaborations. WFBCCC basic science Programs continued to make high impact observations that are being translated into human therapeutics. The WFBCCC requests continued CCSG funding for 4 scientific Programs; 7 Shared Resources; 2 clinical research components; administration and leadership; planning and evaluation; and developmental funds. With these funds, a talented faculty integrated throughout the Cancer Center will make advances in the prevention, early detection, and treatment of cancer in the WFBCCC catchment area and the nation.
    4 schema:endDate 2022-01-31T00:00:00Z
    5 schema:funder https://www.grid.ac/institutes/grid.48336.3a
    6 schema:identifier N8d709a2a848a4143967b65c17dc934ba
    7 Nb02fbcd26289472099e0fdd819536183
    8 schema:inLanguage en
    9 schema:keywords CCSG funding
    10 Cancer Center Support Grant
    11 Center research space
    12 Center?s 127 members
    13 Director?s authority
    14 NCI
    15 North Carolina
    16 Piedmont
    17 Scientific Programs
    18 Shared Resources
    19 Tennessee
    20 U.S.
    21 Virginia
    22 WFBCCC
    23 WFBCCC basic science Programs
    24 WFBCCC cancer research funding
    25 WFBCCC catchment area
    26 WFBCCC clinical facilities
    27 WFBCCC population scientists
    28 WFBCCC requests
    29 West Virginia
    30 administration
    31 advances
    32 buildings
    33 cancer
    34 cancer center
    35 cancer genomics capabilities
    36 cancer incidence
    37 cancer mortality
    38 cancer prevention
    39 cancer research
    40 cancer research excellence
    41 catchment area
    42 clinical research components
    43 clinical scientists
    44 completion
    45 contiguous counties
    46 detection
    47 developmental funds
    48 early detection
    49 elevated age
    50 enhanced tobacco control
    51 enrollment
    52 evaluation
    53 exciting new efforts
    54 faculty
    55 faculty additions
    56 funds
    57 glioma
    58 high impact observations
    59 human therapeutics
    60 incidence
    61 increase
    62 informatics
    63 intra-programmatic productivity
    64 investigators
    65 issues
    66 knowledge
    67 large increase
    68 last CCSG renewal
    69 leadership
    70 lung cancer
    71 majority
    72 nation
    73 new eleven- story Cancer Hospital
    74 number
    75 obesity rates
    76 observations
    77 oncology inpatients
    78 outpatients
    79 patient outcomes
    80 patients
    81 planning
    82 population research
    83 population science
    84 practice
    85 precision medicine
    86 prevention
    87 program
    88 programmatic collaborations
    89 project summaries
    90 prostate cancer
    91 region
    92 rest
    93 services
    94 significant racial health disparities
    95 smoking rates
    96 southern Appalachia
    97 square feet
    98 strategies
    99 study
    100 substantial inter
    101 substantial investment
    102 survivorship
    103 talented faculty
    104 technology
    105 time
    106 tobacco
    107 total cancer funding
    108 treatment
    109 treatment trials
    110 trials
    111 upward trajectory
    112 years
    113 schema:name Cancer Center Support Grant
    114 schema:recipient N72a7ee82ca984a6ea3e015f9b488d0a7
    115 sg:person.0667063306.79
    116 https://www.grid.ac/institutes/grid.412860.9
    117 schema:sameAs https://app.dimensions.ai/details/grant/grant.2438796
    118 schema:sdDatePublished 2019-03-07T12:11
    119 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    120 schema:sdPublisher Ncdf35056a2314578898fc4cad538423f
    121 schema:startDate 1976-03-01T00:00:00Z
    122 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9422670
    123 sgo:license sg:explorer/license/
    124 sgo:sdDataset grants
    125 rdf:type schema:MonetaryGrant
    126 N2214ca9064e54634b3aadd1e45cc2ae5 schema:currency USD
    127 schema:value 31260434
    128 rdf:type schema:MonetaryAmount
    129 N72a7ee82ca984a6ea3e015f9b488d0a7 schema:member sg:person.0667063306.79
    130 schema:roleName PI
    131 rdf:type schema:Role
    132 N8d709a2a848a4143967b65c17dc934ba schema:name nih_id
    133 schema:value P30CA012197
    134 rdf:type schema:PropertyValue
    135 Nb02fbcd26289472099e0fdd819536183 schema:name dimensions_id
    136 schema:value 2438796
    137 rdf:type schema:PropertyValue
    138 Ncdf35056a2314578898fc4cad538423f schema:name Springer Nature - SN SciGraph project
    139 rdf:type schema:Organization
    140 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
    141 rdf:type schema:DefinedTerm
    142 sg:person.0667063306.79 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
    143 schema:familyName PASCHE
    144 schema:givenName BORIS
    145 rdf:type schema:Person
    146 https://www.grid.ac/institutes/grid.412860.9 schema:name WAKE FOREST UNIVERSITY HEALTH SCIENCES
    147 rdf:type schema:Organization
    148 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...